Clinical Trial Update: A Study of CL-197 Capsules in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and pharmacokinetics of CL-197 capsules in healthy participants, with HIV-1 listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CL-197

Snippet

Sponsor: Henan Genuine Biotech Co., Ltd. | Conditions: HIV-1 | Phase 1 | Status: COMPLETED